Indiana 2024 Regular Session Status: Enacted Bipartisan · 9 R · 5 D cosponsors

SB 273 — Biomarker testing coverage.

Last action — Public Law 37

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 11, 2024. Enacted.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 78% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 14 sponsors

    4 primary, 10 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (9 R · 5 D) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 273 on the official Indiana source →

Action History

  1. Public Law 37

  2. Signed by the Governor

  3. Signed by the President of the Senate

  4. Signed by the Speaker

  5. Signed by the President Pro Tempore

  6. Returned to the Senate without amendments

  7. Third reading: passed; Roll Call 236: yeas 94, nays 0

  8. Second reading: ordered engrossed

  9. Committee report: do pass, adopted

  10. Committee report: do pass, adopted

  11. Referred to the Committee on Ways and Means pursuant to House Rule 127

  12. Representative Lehman added as cosponsor

  13. Representative Porter added as cosponsor

  14. Representative Clere added as cosponsor

  15. First reading: referred to Committee on Insurance

  16. Referred to the House

  17. House sponsor: Representative Barrett

  18. Third reading: passed; Roll Call 142: yeas 47, nays 1

  19. Second reading: ordered engrossed

  20. Committee report: amend do pass, adopted

  21. Senator Yoder added as coauthor

  22. Senator Randolph added as coauthor

  23. Senator Ford J.D. added as coauthor

  24. Senator Glick added as coauthor

  25. Senator Bassler added as coauthor

  26. Senator Bohacek added as coauthor

  27. Committee report: amend do pass adopted; reassigned to Committee on Appropriations

  28. Senator Leising added as third author

  29. Senator Qaddoura added as coauthor

  30. Authored by Senators Charbonneau and Becker

  31. First reading: referred to Committee on Insurance and Financial Institutions

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 10 co-sponsors · 136 not signed on

Sponsors (4)

Co-sponsors (10)

Not signed on (136)

136 members have not signed on to this bill.

Show all 136 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 273 do?
Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing.
Who sponsors SB 273?
SB 273 is sponsored by Matt Lehman (Republican), Gregory Porter (Democrat), Edward Clere (Republican), Brad Barrett (Republican), Shelli Yoder (Democrat), Lonnie Randolph (Democrat), J.D. Ford (Democrat), Susan Glick (Republican), Eric Bassler (Republican), Mike Bohacek (Republican), Fady Qaddoura (Democrat), Jean Leising (Republican), Vaneta Becker (Republican), and Ed Charbonneau (Republican).
What is the current status of SB 273?
This bill has been enacted into law. Introduced January 11, 2024. Enacted.
Where can I track SB 273?
Track SB 273 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 273

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 273

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →